These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23639027)

  • 1. Serum B-cell activating factor assessment in a population of Egyptian patients with systemic sclerosis.
    Abdo MS; Mohammed RH; Raslan HM; Gaber SM
    Int J Rheum Dis; 2013 Apr; 16(2):148-56. PubMed ID: 23639027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
    Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
    J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
    Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
    Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.
    Xin G; Cui Z; Su Y; Xu LX; Zhao MH; Li KS
    Nephrology (Carlton); 2013 Mar; 18(3):209-14. PubMed ID: 23317407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma.
    Lei Z; Liu G; Huang Q; Lv M; Zu R; Zhang GM; Feng ZH; Huang B
    Allergy; 2008 Mar; 63(3):327-32. PubMed ID: 18053009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
    Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
    Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum B-cell activating factor in patients with chronic urticaria.
    Kessel A; Yaacoby-Bianu K; Vadasz Z; Peri R; Halazs K; Toubi E
    Hum Immunol; 2012 Jun; 73(6):620-2. PubMed ID: 22504411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
    Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis.
    Peng QL; Shu XM; Wang DX; Wang Y; Lu X; Wang GC
    Biomark Med; 2014; 8(3):395-403. PubMed ID: 24712431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.
    Michalska-Jakubus M; Kowal-Bielecka O; Chodorowska G; Bielecki M; Krasowska D
    Rheumatology (Oxford); 2011 Apr; 50(4):746-55. PubMed ID: 21149250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
    Hedegaard CJ; Sellebjerg F; Krakauer M; Hesse D; Bendtzen K; Nielsen CH
    Mult Scler; 2011 May; 17(5):567-77. PubMed ID: 21177756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential role for B-cell activating factor in the pathogenesis of autoimmune myasthenia gravis.
    Ragheb S; Lisak R; Lewis R; Van Stavern G; Gonzales F; Simon K
    Arch Neurol; 2008 Oct; 65(10):1358-62. PubMed ID: 18852352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
    Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
    Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of B cell-activating factor in autoimmune pancreatitis.
    Yamanishi H; Kumagi T; Yokota T; Azemoto N; Koizumi M; Kobayashi Y; Abe M; Murakami H; Hiasa Y; Matsuura B; Kawamoto H; Yamamoto K; Onji M
    Pancreas; 2011 Aug; 40(6):840-5. PubMed ID: 21747319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.